TxSphere designed its technology to deliver drugs at a higher volume and higher viscosity than traditional autoinjectors.
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end ...
The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results